Active Infection & Immunity Brain & Nervous System

Understanding Zika virus-induced neuropathogenesis and neurotropism

In plain English

AI plain-English summary

Zika virus, once a neglected mosquito-borne disease, now causes microcephaly in newborns—but no one knows exactly how the virus attacks the developing brain. This project aims to solve that mystery. The researcher will compare African and American Zika strains in lab-grown “mini-brains” (cerebral organoids) that mimic human brain development. By tracking which viral genes are active and how human cells respond, they will pinpoint the molecular triggers that make some Zika strains dangerous to fetal brains. They will also test newly discovered virulence factors that differ between the two lineages. If successful, this work will reveal the specific viral proteins and host inflammatory pathways that drive brain damage. That knowledge could guide the design of antiviral drugs that block Zika’s entry into neural cells, or inform vaccine strategies that target the most harmful strains. It could also help public health agencies predict which emerging Zika variants pose the greatest risk to pregnant women. This is fundamental science—it will not produce a treatment tomorrow. But understanding how a virus hijacks brain development is the essential first step toward stopping it.

View original technical description
Zika virus (ZIKV) evolved from an overlooked mosquito-borne flavivirus into a global health threat. However, the molecular mechanisms underlying this new ZIKV neuropathogenicity (e.g., microcephaly) are not understood. I hypothesise differences in tropism and inflammatory host responses, between African and American ZIKV lineages, underlie different pathologies in the developing brain. In a comprehensive approach, I will compare viral replication, viral gene expression, and host responses in a series of tractable models selected to reproduce the in vivo development of the human brain, including cerebral organoids. I will combine RNA sequencing and ribosome profiling methods established in my laboratory to measure virus and host responses, directly comparing African and American isolates. I will then test mechanistic hypotheses formed by manipulating host gene (RNAi/CRISPR-Cas9) or viral gene (reverse genetics mutants) expression and examining effects on virus replication and host response. This will also include the characterisation of the novel virulence factors I recently discovered to differ between African and American ZIKV. In this way, I will gain the most complete understanding of ZIKV inflammation mechanisms and pathogenesis drivers, and the functional viral genetics distinguishing African and American strains, to inform novel therapeutics and public health measures.

View the original record at the funder ↗

Researchers

Nerea Irigoyen (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

How does Musashi 1 enhance Zika virus replication?
The role of ZAP in neuronal protection from alphaviruses and transposable elements
Rethinking the landscape of host defences against emerging viruses
The emergence of Zika virus in Brazil: investigating viral features and host responses to design preventive strategies.
Perturbing the crosstalk between microglia and neurons uncovers mechanisms underpinning neuronal damage and repair in HIV central nervous system infection

Original classification

Career Development Award

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.